BioAmber (BIOA) Tops Q1 EPS by 13c

BioAmber (NYSE: BIOA) reported Q1 EPS of $0.00, $0.13 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $2.12 million versus the consensus estimate of $4.02 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Sprinklr (CXM) Tops Q1 EPS by 1c ; Offers Guidance
• Five Below (FIVE) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY27 Guidance